今週 0 件の言及
0
Social
News
Blog
Moderna and Merck cancer vaccine cuts melanoma recurrence by 44% in late-stage trial
6日前
Moderna and Merck vaccine cuts melanoma recurrence risk by 44% in phase 3 study
